LOMELIA

Serial Number 98792505
686

Registration Progress

Application Filed
Oct 9, 2024
Under Examination
Approved for Publication
Jul 15, 2025
Published for Opposition
Jul 15, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 14, 2025 22 days

Trademark Image

LOMELIA

Basic Information

Serial Number
98792505
Filing Date
October 9, 2024
Published for Opposition
July 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 15, 2025
Application
Pending
Classes
045

Rights Holder

Lomelia

99
Address
38210 Evette CT
Palmdale, CA 93550

Ownership History

Lomelia

Original Applicant
99
Palmdale, CA

Lomelia

Owner at Publication
99
Palmdale, CA

Legal Representation

Attorney
Matt Kulseth

USPTO Deadlines

Next Deadline
22 days remaining
Notice of Publication
Due Date
August 14, 2025
Extension Available
Until September 14, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Jul 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 9, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 6, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 6, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 6, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 18, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 18, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 12, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 10, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 9, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 045
Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication for individuals with chronic kidney disease, patients undergoing dialysis, or individuals in need of organ transplants
First Use Anywhere: Sep 20, 2024
First Use in Commerce: Sep 20, 2024

Classification

International Classes
045